Expected adjusted EBITDA to be in the range of $970 million to $1 billion and expected earnings per common share to be in the range of $2.91 to $3.08.
Expected adjusted EBITDA to be in the range of $970 million to $1 billion and expected earnings per common share to be in the range of $2.91 to $3.08.
Earnings per common share increased 213% to $1.22 for the second quarter, compared to $0.39 for the same quarter last year.
Net income attributable to Select Medical Holdings was $164.9 million in the second quarter and earnings per common share were $1.22.
For the full year of 2021, we now expect revenue in the range of $5.85 billion to $6.05 billion.
Earnings per common share increased 213% to $1.22 for the second quarter, compared to $0.39 for the same quarter last year.
Net income attributable to Select Medical Holdings was $164.9 million in the second quarter and earnings per common share were $1.22.
